NSE announces list of 323 securities subject to Reversal Trade Mechanism (RTCM) effective February 2026.
Impact
Medium
Severity
Medium
Justification
RTCM is a surveillance measure affecting 323 securities with enhanced monitoring and potential trading reversals to manage market risk and protect investors from abnormal price movements.
Curis Lifesciences Limited equity shares admitted to trading on NSE EMERGE SME Platform with effect from November 14, 2025 under Trade for Trade Surveillance Segment.
Impact
Medium
Severity
Medium
Justification
New SME listing on EMERGE platform with Trade for Trade surveillance measures. Impacts SME investors and market makers but limited broader market significance.